Related Experiment Video
Updated: Jun 12, 2026

Genetic Analysis of Hereditary Transthyretin Ala97Ser Related Amyloidosis
Published on: June 9, 2018
Systemic amyloidosis: a challenge for the rheumatologist.
Federico Perfetto1, Alberto Moggi-Pignone, Riccardo Livi
1Department of Internal Medicine, University of Florence, Viale Pieraccini 19, 50139 Firenze, Italy. perfetto@unifi.it
Amyloidosis involves abnormal protein buildup, causing diverse organ damage. Early diagnosis and targeted treatment are crucial for better outcomes in this complex disease.
Area of Science:
- Rheumatology
- Internal Medicine
- Pathology
Background:
- Amyloidosis is a group of diseases defined by extracellular deposition of insoluble fibrillar proteins.
- This deposition leads to various clinical syndromes based on organ involvement.
- It is classified into systemic and localized forms, with systemic amyloidosis having several subtypes.
Purpose of the Study:
- To review the clinical features and rheumatic manifestations of amyloidosis.
- To present the different types of amyloidosis, their prognoses, and treatment strategies.
Main Methods:
- Literature review of amyloidosis, focusing on clinical presentation and rheumatologic aspects.
- Discussion of diagnostic criteria, prognostic factors, and therapeutic approaches.
Main Results:
- Amyloidosis presents with diverse symptoms depending on the affected organs.
- Rheumatologic symptoms are common, leading patients to consult rheumatologists.
- Systemic amyloidosis includes hereditary (ATTR), reactive (AA), dialysis-related (Abeta(2)M), and light chain (AL) forms.
Conclusions:
- Early diagnosis of amyloidosis is critical for effective treatment and improved prognosis.
- Treatment strategies target symptoms or aim to reduce abnormal protein production.
- Despite advances, prognosis remains challenging and depends on disease type and organ dysfunction.
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Nephrotic Syndrome I : Introduction
Nephrotic Syndrome II : Assessment and Medical Management